{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:11:25Z","timestamp":1792800685512,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":28,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Funds for the innovation of science and Technology, Fujian province","award":["2024Y9307;2024Y9480;2023Y9202"],"award-info":[{"award-number":["2024Y9307;2024Y9480;2023Y9202"]}]},{"name":"Fujian Provincial Department of Science and Technology Guiding Science and Technology Planning Project","award":["2024Y0022"],"award-info":[{"award-number":["2024Y0022"]}],"id":[{"id":"https:\/\/ror.org\/00rgzpv08","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-04013-6","type":"journal-article","created":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T07:37:07Z","timestamp":1767771427000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Biomimetic PD-1-nanovesicles inducing tri-modal sonodynamic-chemo-immunotherapy for breast cancer therapy and lung metastasis inhibition"],"prefix":"10.1186","volume":"24","author":[{"given":"Wenjin","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenhu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haidong","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaodong","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiujuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,7]]},"reference":[{"key":"4013_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4013_CR2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s12957-022-02508-2","volume":"20","author":"S Liu","year":"2022","unstructured":"Liu S, et al. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer. World J Surg Oncol. 2022;20:71.","journal-title":"World J Surg Oncol"},{"key":"4013_CR3","doi-asserted-by":"publisher","first-page":"14017","DOI":"10.1039\/D4RA02639J","volume":"14","author":"SL Mugundhan","year":"2024","unstructured":"Mugundhan SL, Mohan M. Nanoscale strides: exploring innovative therapies for breast cancer treatment. RSC Adv. 2024;14:14017\u201340.","journal-title":"RSC Adv"},{"key":"4013_CR4","doi-asserted-by":"publisher","DOI":"10.3390\/cancers17121945","author":"T Sanomachi","year":"2025","unstructured":"Sanomachi T, Katsuya Y, Nakatsura T, Koyama T. Next-generation CAR-T and TCR-T cell therapies for solid tumors: innovations, challenges, and global development trends. Cancers (Basel). 2025. https:\/\/doi.org\/10.3390\/cancers17121945.","journal-title":"Cancers (Basel)"},{"key":"4013_CR5","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1158\/2159-8290.CD-23-0299","volume":"13","author":"I Yofe","year":"2023","unstructured":"Yofe I, et al. Spatial and temporal mapping of breast cancer lung metastases identify TREM2 macrophages as regulators of the metastatic boundary. Cancer Discov. 2023;13:2610\u201331.","journal-title":"Cancer Discov"},{"key":"4013_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-019-1487-6","volume":"572","author":"L Ombrato","year":"2019","unstructured":"Ombrato L, et al. Metastatic-niche labelling reveals parenchymal cells with stem features. Nature. 2019;572:603\u20138.","journal-title":"Nature"},{"key":"4013_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202308977","volume":"36","author":"X Zheng","year":"2024","unstructured":"Zheng X, et al. Nanomedicine combats drug resistance in lung cancer. Adv Mater. 2024;36:e2308977.","journal-title":"Adv Mater"},{"key":"4013_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/adhm.202304249","volume":"13","author":"C Cao","year":"2024","unstructured":"Cao C, et al. Time and space dual-blockade strategy for highly invasive nature of triple-negative breast cancer in enhanced sonodynamic therapy based on Fe-MOF nanoplatforms. Adv Healthc Mater. 2024;13:e2304249.","journal-title":"Adv Healthc Mater"},{"key":"4013_CR9","doi-asserted-by":"publisher","first-page":"5837","DOI":"10.2147\/IJN.S466042","volume":"19","author":"Y Wang","year":"2024","unstructured":"Wang Y, et al. Tumor Cell-Targeting and Tumor Microenvironment-Responsive Nanoplatforms for the Multimodal Imaging-Guided Photodynamic\/Photothermal\/Chemodynamic Treatment of Cervical Cancer. Int J Nanomedicine. 2024;19:5837\u201358.","journal-title":"Int J Nanomedicine"},{"key":"4013_CR10","doi-asserted-by":"publisher","first-page":"14212","DOI":"10.1002\/anie.201906823","volume":"59","author":"X Lin","year":"2020","unstructured":"Lin X, Song J, Chen X, Yang H. Ultrasound-activated sensitizers and applications. Angew Chem Int Ed Engl. 2020;59:14212\u201333.","journal-title":"Angew Chem Int Ed Engl"},{"key":"4013_CR11","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202312124","volume":"36","author":"R Niu","year":"2024","unstructured":"Niu R, et al. Programmed targeting pyruvate metabolism therapy amplified single-atom nanozyme-activated pyroptosis for immunotherapy. Adv Mater. 2024;36:e2312124.","journal-title":"Adv Mater"},{"key":"4013_CR12","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202003214","volume":"32","author":"S Liang","year":"2020","unstructured":"Liang S, Deng X, Ma P, Cheng Z, Lin J. Recent advances in nanomaterial-assisted combinational sonodynamic cancer therapy. Adv Mater. 2020;32:e2003214.","journal-title":"Adv Mater"},{"key":"4013_CR13","doi-asserted-by":"publisher","first-page":"5154","DOI":"10.1038\/s41467-025-60293-4","volume":"16","author":"WC Liu","year":"2025","unstructured":"Liu WC, et al. Inhibition of tumor-intrinsic NAT10 enhances antitumor immunity by triggering type I interferon response via MYC\/CDK2\/DNMT1 pathway. Nat Commun. 2025;16:5154.","journal-title":"Nat Commun"},{"key":"4013_CR14","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1186\/s12951-025-03453-4","volume":"23","author":"E Wen","year":"2025","unstructured":"Wen E, et al. Tumor microenvironment responsive Mn-based nanoplatform activate cGAS-STING pathway combined with metabolic interference for enhanced anti-tumor therapy. J Nanobiotechnology. 2025;23:377.","journal-title":"J Nanobiotechnology"},{"key":"4013_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/mdb2.70002","volume":"1","author":"G Wan","year":"2025","unstructured":"Wan G, Huang J-D, Xu R-H, Jin M. Advances and challenges in pluripotent stem cell-based whole-cell vaccines for cancer treatment. Medicine Bulletin. 2025;1:60\u201376.","journal-title":"Medicine Bulletin"},{"key":"4013_CR16","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1158\/1078-0432.CCR-21-3844","volume":"28","author":"O Akinboro","year":"2022","unstructured":"Akinboro O, et al. FDA approval summary: pembrolizumab, atezolizumab, and cemiplimab-rwlc as single agents for first-line treatment of advanced\/metastatic PD-L1-high NSCLC. Clin Cancer Res. 2022;28:2221\u20138.","journal-title":"Clin Cancer Res"},{"key":"4013_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202400951","volume":"11","author":"Y Sun","year":"2024","unstructured":"Sun Y, et al. Multifunctional biomimetic nanocarriers for dual-targeted immuno-gene therapy against hepatocellular carcinoma. Adv Sci. 2024;11:e2400951.","journal-title":"Adv Sci"},{"key":"4013_CR18","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","volume":"391","author":"A Forner","year":"2018","unstructured":"Forner A, Reig M, Bruix J. Hepatocellular carcinoma. Lancet. 2018;391:1301\u201314.","journal-title":"Lancet"},{"key":"4013_CR19","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202300878","volume":"10","author":"Y Qiu","year":"2023","unstructured":"Qiu Y, et al. Nano ultrasound contrast agent for synergistic chemo-photothermal therapy and enhanced immunotherapy against liver cancer and metastasis. Adv Sci. 2023;10:e2300878.","journal-title":"Adv Sci"},{"key":"4013_CR20","doi-asserted-by":"publisher","first-page":"11026","DOI":"10.1039\/C9RA00834A","volume":"9","author":"Y Chen","year":"2019","unstructured":"Chen Y, et al. Spermine modified polymeric micelles with pH-sensitive drug release for targeted and enhanced antitumor therapy. RSC Adv. 2019;9:11026\u201337.","journal-title":"RSC Adv"},{"key":"4013_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.colsurfb.2025.115249","volume":"258","author":"S Bhagat","year":"2026","unstructured":"Bhagat S, Arora P, Babu K, Singh S. PD-L1 antibody decorated chemiluminescence producing Au-Ag nanoalloys for targeted detection of hepatic cancer cells. Colloids Surf B Biointerfaces. 2026;258:115249.","journal-title":"Colloids Surf B Biointerfaces"},{"key":"4013_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-025-02217-8","volume":"10","author":"J Guo","year":"2025","unstructured":"Guo J, et al. Bio-barrier-adaptable biomimetic nanomedicines combined with ultrasound for enhanced cancer therapy. Signal Transduct Target Ther. 2025;10:137.","journal-title":"Signal Transduct Target Ther"},{"key":"4013_CR23","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41571-022-00699-x","volume":"20","author":"RH Fang","year":"2023","unstructured":"Fang RH, Gao W, Zhang L. Targeting drugs to tumours using cell membrane-coated nanoparticles. Nat Rev Clin Oncol. 2023;20:33\u201348.","journal-title":"Nat Rev Clin Oncol"},{"key":"4013_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-61230-1","volume":"16","author":"L Cui","year":"2025","unstructured":"Cui L, et al. Bioengineered nanovesicles for efficient siRNA delivery through ligand-receptor-mediated and enzyme-controlled membrane fusion. Nat Commun. 2025;16:6174.","journal-title":"Nat Commun"},{"key":"4013_CR25","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1007\/s40005-025-00731-z","volume":"55","author":"HM Yuan","year":"2025","unstructured":"Yuan HM, et al. Disulfide bond-driven nanoassembly of lipophilic epirubicin prodrugs for breast cancer therapy. J Pharm Investig. 2025;55:889\u2013902.","journal-title":"J Pharm Investig"},{"key":"4013_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics16121582","author":"C Feng","year":"2024","unstructured":"Feng C, et al. Precisely tailoring molecular structure of doxorubicin prodrugs to enable stable nanoassembly, rapid activation, and potent antitumor effect. Pharmaceutics. 2024. https:\/\/doi.org\/10.3390\/pharmaceutics16121582.","journal-title":"Pharmaceutics"},{"key":"4013_CR27","doi-asserted-by":"publisher","first-page":"9945","DOI":"10.1039\/D1NR01916C","volume":"13","author":"D Wang","year":"2021","unstructured":"Wang D, et al. Ultrasound responsive erythrocyte membrane-derived hybrid nanovesicles with controlled drug release for tumor therapy. Nanoscale. 2021;13:9945\u201351.","journal-title":"Nanoscale"},{"key":"4013_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioadv.2024.213771","volume":"158","author":"S Maghsoudian","year":"2024","unstructured":"Maghsoudian S, et al. Targeted pH- and redox-responsive AuS\/micelles with low CMC for highly efficient sonodynamic therapy of metastatic breast cancer. Biomater Adv. 2024;158:213771.","journal-title":"Biomater Adv"},{"key":"4013_CR29","doi-asserted-by":"publisher","first-page":"7738","DOI":"10.1021\/acsnano.6b03148","volume":"10","author":"H Cao","year":"2016","unstructured":"Cao H, et al. Liposomes coated with isolated macrophage membrane can target lung metastasis of breast cancer. ACS Nano. 2016;10:7738\u201348.","journal-title":"ACS Nano"},{"key":"4013_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2025.102116","volume":"34","author":"D Wusiman","year":"2025","unstructured":"Wusiman D, et al. Biomimetic nanovaccines in cancer therapy: mechanisms, efficacy, and clinical translation. Mater Today Bio. 2025;34:102116.","journal-title":"Mater Today Bio"},{"key":"4013_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101441","volume":"30","author":"N Cheng","year":"2025","unstructured":"Cheng N, et al. Functionalized biomimetic nanoparticles loaded with salvianolic acid B for synergistic targeted triple-negative breast cancer treatment. Mater Today Bio. 2025;30:101441.","journal-title":"Mater Today Bio"},{"key":"4013_CR32","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-025-03583-9","volume":"23","author":"A Zhang","year":"2025","unstructured":"Zhang A, et al. Sonodynamic biomimetic-nanomedicine fight cancers. J Nanobiotechnology. 2025;23:548.","journal-title":"J Nanobiotechnology"},{"key":"4013_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202410427","volume":"12","author":"T Luo","year":"2025","unstructured":"Luo T, et al. Biomimetic targeted co-delivery system engineered from genomic insights for precision treatment of osteosarcoma. Adv Sci. 2025;12:e2410427.","journal-title":"Adv Sci"},{"key":"4013_CR34","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1038\/s41565-021-00972-7","volume":"16","author":"Y Zhai","year":"2021","unstructured":"Zhai Y, et al. T lymphocyte membrane-decorated epigenetic nanoinducer of interferons for cancer immunotherapy. Nat Nanotechnol. 2021;16:1271\u201380.","journal-title":"Nat Nanotechnol"},{"key":"4013_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.mtbio.2024.101067","volume":"26","author":"J Lin","year":"2024","unstructured":"Lin J, et al. Enhancing glioma-specific drug delivery through self-assembly of macrophage membrane and targeted polymer assisted by low-frequency ultrasound irradiation. Mater Today Bio. 2024;26:101067.","journal-title":"Mater Today Bio"},{"key":"4013_CR36","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1186\/s12951-022-01673-6","volume":"20","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Cell membrane-coated human hair nanoparticles for precise disease therapies. J Nanobiotechnol. 2022;20:480.","journal-title":"J Nanobiotechnol"},{"key":"4013_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.actbio.2021.05.018","volume":"129","author":"W Chen","year":"2021","unstructured":"Chen W, Yu D, Sun SY, Li F. Nanoparticles for co-delivery of osimertinib and selumetinib to overcome osimertinib-acquired resistance in non-small cell lung cancer. Acta Biomater. 2021;129:258\u201368.","journal-title":"Acta Biomater"},{"key":"4013_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202512578","author":"Y Huang","year":"2025","unstructured":"Huang Y, et al. Mild photothermal bimetallic mesoporous nanozyme triggers immunogenic cell death and immune contexture remodeling for precision hepatocellular carcinoma treatment. Adv Sci (Weinh). 2025. https:\/\/doi.org\/10.1002\/advs.202512578.","journal-title":"Adv Sci (Weinh)"},{"key":"4013_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2025.103843","volume":"86","author":"D Han","year":"2025","unstructured":"Han D, et al. Small extracellular vesicles orchestrated pathological communications between breast cancer cells and cardiomyocytes as a novel mechanism exacerbating anthracycline cardiotoxicity by fueling ferroptosis. Redox Biol. 2025;86:103843.","journal-title":"Redox Biol"},{"key":"4013_CR40","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12943-024-02176-8","volume":"23","author":"M Jin","year":"2024","unstructured":"Jin M, et al. PD-1\/PD-L1 immune checkpoint blockade in breast cancer: research insights and sensitization strategies. Mol Cancer. 2024;23:266.","journal-title":"Mol Cancer"},{"key":"4013_CR41","doi-asserted-by":"publisher","first-page":"9413","DOI":"10.1021\/acsnano.3c11023","volume":"18","author":"X Xu","year":"2024","unstructured":"Xu X, et al. Bioorthogonal\/Ultrasound activated oncolytic pyroptosis amplifies in situ tumor vaccination for boosting antitumor immunity. ACS Nano. 2024;18:9413\u201330.","journal-title":"ACS Nano"},{"key":"4013_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/adma.202409618","volume":"36","author":"W Wei","year":"2024","unstructured":"Wei W, et al. Ultrasmall enzyodynamic PANoptosis nano-inducers for ultrasound-amplified hepatocellular carcinoma therapy and lung metastasis inhibition. Adv Mater. 2024;36:e2409618.","journal-title":"Adv Mater"},{"key":"4013_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s12951-024-02514-4","volume":"22","author":"X Jiang","year":"2024","unstructured":"Jiang X, et al. Greatly isolated heterogeneous circulating tumor cells using hybrid engineered cell membrane-camouflaged magnetic nanoparticles. J Nanobiotechnology. 2024;22:231.","journal-title":"J Nanobiotechnology"},{"key":"4013_CR44","doi-asserted-by":"publisher","first-page":"2486","DOI":"10.1158\/1535-7163.MCT-17-0241","volume":"16","author":"AS Harney","year":"2017","unstructured":"Harney AS, et al. The selective Tie2 inhibitor rebastinib blocks recruitment and function of Tie2(Hi) macrophages in breast cancer and pancreatic neuroendocrine tumors. Mol Cancer Ther. 2017;16:2486\u2013501.","journal-title":"Mol Cancer Ther"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-04013-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-04013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-04013-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T19:01:59Z","timestamp":1784314919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12951-025-04013-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,7]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4013"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-04013-6","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,7]]},"assertion":[{"value":"4 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":6,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":7,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised: Funding has been updated.","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All animal experiments were conducted following the approved animal protocol procedures by the Institutional Animal Care and Use Committee (IACUC) of Fujian Medical University, which are consistent with the International Council for Laboratory Animal Science (ICLAS) guidelines.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"116"}}